Intrafamilial phenotypic heterogeneity in siblings with pseudohypoparathyroidism 1B due to maternal deletion.

J Pediatr Endocrinol Metab

Department of Pediatrics, Division of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Published: January 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: Pseudohypoparathyroidism (PHP1B) is most commonly caused by epigenetic defects resulting in loss of methylation at the GNAS locus, although deletions of leading to GNAS methylation abnormalities have been previously reported. The phenotype of this disorder is variable and can include hormonal resistances and severe infantile obesity with hyperphagia. A possible time relationship between the onset of obesity and endocrinopathies has been previously reported but remains unclear. Understanding of the condition's natural history is limited, partly due to a scarcity of literature, especially in children.

Case Presentation: We report three siblings with autosomal dominant PHP1B caused by a deletion in who presented with early childhood onset PTH-resistance with normocalcemia with a progressive nature, accompanied by TSH-resistance and severe infantile obesity with hyperphagia in some, not all of the affected individuals.

Conclusions: PHP1B from a deletion displays intrafamilial phenotypic variation. It is a novel cause of severe infantile obesity, which is not typically included in commercially available gene panels but must be considered in the genetic work-up. Finally, it does not seem to have a clear time relationship between the onset of obesity and hormonal resistance.

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem-2023-0249DOI Listing

Publication Analysis

Top Keywords

severe infantile
12
infantile obesity
12
intrafamilial phenotypic
8
obesity hyperphagia
8
time relationship
8
relationship onset
8
onset obesity
8
obesity
5
phenotypic heterogeneity
4
heterogeneity siblings
4

Similar Publications

Developmental and epileptic encephalopathies (DEEs), including Infantile Epileptic Spasms Syndrome (IESS) and Lennox-Gastaut Syndrome (LGS), are severe pediatric conditions characterized by profound developmental delays and treatment-resistant epilepsy. Although steroid therapies provide some clinical benefits, the underlying immunological mechanisms remain poorly understood. In this study, we performed comprehensive immune profiling using multi-parametric flow cytometry on PBMCs from IESS (n=25) and LGS (n=9) patients, comparing them with age-matched healthy controls (n=54).

View Article and Find Full Text PDF

Infantile Epileptic Spasms Syndrome (IESS), also referred to as West syndrome, is a severe epileptic disorder that emerges during early childhood. It is marked by characteristic epileptic spasms, developmental stagnation or regression, and a distinctive electroencephalogram (EEG) pattern known as hypsarrhythmia. To better understand the underlying mechanisms of IESS, various genetic and chemically induced animal models have been developed.

View Article and Find Full Text PDF

Objective: Electronic health records offer the opportunity for quality-improvement (QI) initiatives addressing health disparities in epilepsy care. The Pediatric Epilepsy Outcome-Informatics Project (PEOIP) at Alberta Children's Hospital implemented point-of-care data entry into a standardized pediatric epilepsy electronic note as part of routine clinical care to support QI initiatives. Our study validated collected data by assessing the prevalence of patient characteristics, ethno-racial background, and 4 of the most common severe epilepsy syndromes: infantile epileptic spasms, Dravet, Lennox-Gastaut, and developmental epileptic encephalopathy with spike-wave action in sleep.

View Article and Find Full Text PDF

Background: The Burden of AmplitudeS and Epileptiform Discharges (BASED) and "Hypsarrhythmia Scoring System" (HSS) serve to evaluate the interictal EEG in infantile epileptic spasms (ES) syndrome (IESS). We aimed to assess these scoring systems' reliability and diagnostic utility in infants with IESS and other developmental and epileptic encephalopathies (DEEs) without ES.

Methods: Three epileptologists from a single medical center scored the deidentified EEG tracings of 110 infants, 58 with IESS, and 52 with other DEEs (of similar age and sex distributions), according to the BASED and HSS scoring systems.

View Article and Find Full Text PDF

Pompe disease (PD) is a multisystemic progressive disease caused by acid-alpha glucosidase (GAA) deficiency. Patients display a spectrum of phenotypes ranging from the severe, rapidly progressive infantile-onset PD (IOPD) form to the slower progressing late-onset PD (LOPD). Enzyme replacement therapies (ERTs) are the only approved treatments; they decrease mortality in IOPD while maintaining or improving motor and respiratory function in LOPD.

View Article and Find Full Text PDF